Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Cellular and Molecular Medicine
|
March 28, 2006
SUMO-1 modification of MEF2A regulates its transcriptional activity
Cecilia Riquelme, Kristen K B Barthel, Xuedong Liu
Matrix Biology : Journal of the International Society for Matrix Biology
|
June 13, 2006
Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation
Rebeca Droguett, Claudio Cabello-Verrugio, Cecilia Riquelme, et al.
Experimental Cell Research
|
April 25, 2006
Ubc9 expression is essential for myotube formation in C2C12
Cecilia Riquelme, Kristen K B Barthel, Xiao-Feng Qin, et al.
Kidney International Reports
|
June 11, 2020
Using Telenephrology to Improve Access to Nephrologist and Global Kidney Management of CKD Primary Care Patients
Carlos Zuniga, Cecilia Riquelme, Hans Muller, et al.
Biofactors (Oxford, England)
|
March 6, 2013
Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle
Paula Painemal, María José Acuña, Cecilia Riquelme, et al.
Plos One
|
April 4, 2014
ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis
Cecilia Riquelme, María José Acuña, Javiera Torrejón, et al.
Nucleic Acids Research
|
February 1, 2011
Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly
Ju He, Jun Ye, Yongfei Cai, et al.
Biofactors (Oxford, England)
|
March 27, 2015
Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies
Catalina Cofre, María José Acuña, Osvaldo Contreras, et al.
Biofactors (Oxford, England)
|
June 23, 2015
Erratum for: Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies
Catalina Cofre, María José Acuña, Osvaldo Contreras, et al.
The Journal of Biological Chemistry
|
October 26, 2002
Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta
Fernando Lopez-Casillas, Cecilia Riquelme, Yoshiaki Perez-Kato, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Cellular and Molecular Medicine
|
March 28, 2006
SUMO-1 modification of MEF2A regulates its transcriptional activity
Cecilia Riquelme, Kristen K B Barthel, Xuedong Liu
Matrix Biology : Journal of the International Society for Matrix Biology
|
June 13, 2006
Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation
Rebeca Droguett, Claudio Cabello-Verrugio, Cecilia Riquelme, et al.
Experimental Cell Research
|
April 25, 2006
Ubc9 expression is essential for myotube formation in C2C12
Cecilia Riquelme, Kristen K B Barthel, Xiao-Feng Qin, et al.
Kidney International Reports
|
June 11, 2020
Using Telenephrology to Improve Access to Nephrologist and Global Kidney Management of CKD Primary Care Patients
Carlos Zuniga, Cecilia Riquelme, Hans Muller, et al.
Biofactors (Oxford, England)
|
March 6, 2013
Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle
Paula Painemal, María José Acuña, Cecilia Riquelme, et al.
Plos One
|
April 4, 2014
ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis
Cecilia Riquelme, María José Acuña, Javiera Torrejón, et al.
Nucleic Acids Research
|
February 1, 2011
Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly
Ju He, Jun Ye, Yongfei Cai, et al.
Biofactors (Oxford, England)
|
March 27, 2015
Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies
Catalina Cofre, María José Acuña, Osvaldo Contreras, et al.
Biofactors (Oxford, England)
|
June 23, 2015
Erratum for: Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies
Catalina Cofre, María José Acuña, Osvaldo Contreras, et al.
The Journal of Biological Chemistry
|
October 26, 2002
Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta
Fernando Lopez-Casillas, Cecilia Riquelme, Yoshiaki Perez-Kato, et al.
Page
of 2